BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38131796)

  • 1. Phenotypic Characterization of 2D and 3D Prostate Cancer Cell Systems Using Electrical Impedance Spectroscopy.
    Crowell LL; Yakisich JS; Aufderheide B; Adams TNG
    Biosensors (Basel); 2023 Dec; 13(12):. PubMed ID: 38131796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic-based prostate cancer model for investigating the secretion of prostate-specific antigen and microRNAs in vitro.
    Padmyastuti A; Sarmiento MG; Dib M; Ehrhardt J; Schoon J; Somova M; Burchardt M; Roennau C; Pinto PC
    Sci Rep; 2023 Jul; 13(1):11623. PubMed ID: 37468746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Microfluidic System for Electrochemical Impedance Spectroscopy Assessment of Cell Culture Performance: Design and Development of New Electrode Material.
    Chmayssem A; Tanase CE; Verplanck N; Gougis M; Mourier V; Zebda A; Ghaemmaghami AM; Mailley P
    Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dielectrophoretic and Electrical Impedance Differentiation of Cancerous Cells Based on Biophysical Phenotype.
    Turcan I; Caras I; Schreiner TG; Tucureanu C; Salageanu A; Vasile V; Avram M; Tincu B; Olariu MA
    Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo biomarker expression patterns are preserved in 3D cultures of Prostate Cancer.
    Windus LC; Kiss DL; Glover T; Avery VM
    Exp Cell Res; 2012 Nov; 318(19):2507-19. PubMed ID: 22841689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of prostate cancer cell lines and their epithelial-mesenchymal transition in subcutaneous tumors].
    Zhao L; Jiang YG; Ma J; Luo Y; Zhao JH
    Zhonghua Nan Ke Xue; 2011 Apr; 17(4):314-7. PubMed ID: 21548207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells.
    Fontana F; Raimondi M; Marzagalli M; Sommariva M; Limonta P; Gagliano N
    Cells; 2019 Feb; 8(2):. PubMed ID: 30754655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical Impedance Spectroscopy for Monitoring Chemoresistance of Cancer Cells.
    Crowell LL; Yakisich JS; Aufderheide B; Adams TNG
    Micromachines (Basel); 2020 Aug; 11(9):. PubMed ID: 32878225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concepts, electrode configuration, characterization, and data analytics of electric and electrochemical microfluidic platforms: a review.
    Nguyen TH; Nguyen HA; Tran Thi YV; Hoang Tran D; Cao H; Chu Duc T; Bui TT; Do Quang L
    Analyst; 2023 May; 148(9):1912-1929. PubMed ID: 36928639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical Impedance Spectroscopy for Characterization of Prostate PC-3 and DU 145 Cancer Cells.
    Teixeira VS; Barth T; Labitzky V; Schumacher U; Krautschneider W
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():6485-6489. PubMed ID: 31947327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia and the metabolic phenotype of prostate cancer cells.
    Higgins LH; Withers HG; Garbens A; Love HD; Magnoni L; Hayward SW; Moyes CD
    Biochim Biophys Acta; 2009 Dec; 1787(12):1433-43. PubMed ID: 19524545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.
    Härmä V; Virtanen J; Mäkelä R; Happonen A; Mpindi JP; Knuuttila M; Kohonen P; Lötjönen J; Kallioniemi O; Nees M
    PLoS One; 2010 May; 5(5):e10431. PubMed ID: 20454659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines.
    Hirsch GE; Parisi MM; Martins LA; Andrade CM; Barbé-Tuana FM; Guma FT
    Prostate; 2015 Jun; 75(8):783-97. PubMed ID: 25619388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.
    Schmitt J; Noble A; Otsuka M; Berry P; Maitland NJ; Rumsby MG
    Br J Cancer; 2014 Oct; 111(8):1646-56. PubMed ID: 25137020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
    Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
    Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinularin Exerts Anti-cancer Effects by Inducing Oxidative Stress-mediated Ferroptosis, Apoptosis, and Autophagy in Prostate Cancer Cells.
    Wu Z; Su M; Chen H; Chen X; Chen CY; An L; Shao Z; Liu X; Lin Y; OuYang AJ; Liu CM
    Anticancer Agents Med Chem; 2023; 23(12):1457-1468. PubMed ID: 37005535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines.
    Szyszka M; Tyczewska M; Milecka P; Jopek K; Celichowski P; Malendowicz LK; Rucinski M
    Oncol Rep; 2018 Jan; 39(1):182-192. PubMed ID: 29115533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
    Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
    Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.